Why Educating Yourself Matters Before Starting Hormone Therapy — Not Many Conditions are Truly Red Flags When it Comes to Estrogen

When considering hormone therapy for perimenopause or menopause, many women (and unfortunately many clinicians) make the mistake of assuming that certain conditions like elevated cholesterol automatically disqualify someone from estrogen therapy. That’s simply not true — but only if both the patient and their provider understand the evidence and choose the right type and route of therapy.

One of the most common fears women express when considering hormone therapy is:

“What if my cholesterol is high? Will estrogen make it worse?”

The answer isn’t a simple yes or no — and that’s exactly why education matters.

Not All Estrogen Is Created Equal

A 2025 systematic review and meta-analysis looked at how oral vs. transdermal estrogen therapy affects cardiovascular and lipid parameters in postmenopausal women. This analysis included data from eight randomized clinical trials (885 women) comparing the two routes of administration.

Here’s what the evidence showed:

🔹 Oral Estrogen

• Was associated with a greater increase in high-density lipoprotein (HDL) (“good” cholesterol).

• Also led to a significant rise in triglyceride levels, which can be concerning for cardiovascular risk in some women.

🔹 Transdermal Estrogen

• Did not produce the same rise in triglycerides seen with oral estrogen.

• Had no significant effect on total cholesterol or LDL (“bad” cholesterol) levels compared with oral estrogen.

In other words, women with elevated cholesterol may experience different lipid effects depending on the route of estrogen therapy. This is not a blanket “estrogen will worsen cholesterol” situation — it’s about how estrogen is delivered and how your body responds.

Other Evidence on Lipids and Estrogen

🔹 Both Oral and Transdermal Estrogen Lower Atherogenic Lipoproteins

Older randomized trials found that both oral and transdermal estrogen reduced Lp(a), a cholesterol-related lipoprotein linked to cardiovascular risk, and lowered total and LDL cholesterol after a few months of therapy.

🔹 Transdermal Estrogen May Lower Triglycerides

Some studies have shown that while oral estrogen tends to raise triglycerides, transdermal estrogen can actually be neutral or even reduce triglyceride levels compared to baseline (and compared to oral).

What This Means for You

🔹 1. Elevated Cholesterol Is Not a Guaranteed “No” for Estrogen

The assumption that high cholesterol automatically prohibits estrogen therapy is outdated. The route of estrogen matters. Transdermal estrogen (patches, gels) does not have the same impact on triglycerides and total cholesterol as oral estrogen, and may be better tolerated metabolically.

🔹 2. The Choice of Hormone Route Should Be Individualized

Your clinician should consider your overall health, lipid profile, cardiovascular risk, and symptoms when recommending:

• Transdermal estradiol

• Oral estrogen

• Micronized progesterone

• Combination therapy

🔹 3. Not All Clinicians Are Up to Date

If your provider treats elevated cholesterol as a categorical contraindication to estrogen — rather than as a factor to weigh alongside route, dose, and individual risk — it may be time to seek someone who keeps abreast of modern data.

Bottom Line

Your health decisions deserve nuance. Elevated cholesterol does not automatically rule out estrogen therapy — particularly when delivered through a transdermal route, which seems neutral or favorable for lipid profiles compared with oral estrogen.

Hormone therapy isn’t a one-size-fits-all treatment, and understanding the why behind the choices — especially the impact on lipids and heart risk — empowers you to advocate for the right regimen.

References (for clinicians or patients who want the science)

• Doma M, Loayza Pintado J, Atwal A, et al. Efficacy of oral versus transdermal estrogen therapy on cardiovascular and lipid parameters among postmenopausal women: a systematic review and meta-analysis of randomized clinical trials. Menopause. 2025 Nov 4.

• Meschia M, et al. Effects of oral and transdermal hormone replacement therapy on lipoprotein(a) and lipids. Menopause. 1998.

• Randomized comparison of transdermal vs oral estrogen/progestin and effects on serum lipids.

• Long-term transdermal vs oral estrogen effects on triglycerides and cholesterol.